首页> 美国卫生研究院文献>PLoS Clinical Trials >Establishment and application of isothermal multiple-self-matching-initiated amplification (IMSA) in detecting Type II heat-labile enterotoxin of Escherichia coli
【2h】

Establishment and application of isothermal multiple-self-matching-initiated amplification (IMSA) in detecting Type II heat-labile enterotoxin of Escherichia coli

机译:等温多次自匹配扩增(IMSA)技术在大肠杆菌II型不耐热肠毒素检测中的建立及应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Enterotoxigenic Escherichia coli (ETEC) constitutes a major cause of diarrhea in young children and animals, particularly in poor regions of the world, as well the traveler’s diarrhea in adult individuals. Type II heat-labile enterotoxin (LT-II) from ETEC can cause profuse watery diarrhea, posing a potential threat to public health and animal husbandry. In the present study, isothermal multiple-self-matching-initiated amplification (IMSA) was established to rapidly detect LT-II producing ETEC. The specificity and sensitivity were assessed, and clinical samples were tested. The established IMSA method had good specificity for the detection of LT-II gene with a limit of detection of 25 CFU/mL, i.e. 2 times higher than that of real-time PCR and other two isothermal amplifications (loop-mediated isothermal amplification, LAMP and cross-primer isothermal amplification, CPA). Meanwhile, in 103 clinical Escherichia coli strains isolated from diarrhea samples, 9 strains with LT-II+ gene were detected (8.73%), corroborating real-time PCR, LAMP and CPA data. Therefore, the IMSA technology applied for the detection of LT-II producing ETEC has a good application prospect for screening clinical samples in primary medical units or common laboratories.
机译:产肠毒素的大肠杆菌(ETEC)是导致幼儿和动物(特别是在世界贫困地区)腹泻以及成年旅客腹泻的主要原因。 ETEC产生的II型不耐热肠毒素(LT-II)会引起大量水样腹泻,对公共卫生和畜牧业构成潜在威胁。在本研究中,建立了等温多重自匹配引发的扩增(IMSA)以快速检测产生LT-II的ETEC。评估了特异性和敏感性,并测试了临床样本。建立的IMSA方法对LT-II基因的检测具有良好的特异性,检测极限为25 CFU / mL,即比实时PCR和其他两个等温扩增(环介导的等温扩增,LAMP)高2倍。和跨引物等温扩增(CPA)。同时,在从腹泻样品中分离出的103株临床大肠杆菌中,检出9株具有LT-II + 基因的菌株(8.73%),证实了实时PCR,LAMP和CPA数据的准确性。因此,用于检测产生LT-II的ETEC的IMSA技术在筛查基层医疗单位或普通实验室中的临床样本方面具有良好的应用前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号